Sign inJoin waitlistJoin the waitlist

Asona Lui

Assistant Professor of Radiation Medicine and Applied Sciences · University of California (San Diego) Medical Center

Credentials: · · · ·

History

University of California (San Diego) Medical Center
Present

Radiation Oncology
University of California (San Diego) Medical Center
2020–2024
Preliminary or Transitional Year
2019–2020
University of Kansas, Kansas City KS 2017
Univ of Kansas Sch of Med
2015–2019

Research

Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator…
Breast Cancer Research · 2016 · 74 citations
Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells
BMC Cancer · 2016 · First of 5 authors · 61 citations
IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21
Cancer Letters · 2017 · First of 9 authors · 56 citations

Tyler Seibert
10 papers
AZ
Allison Zhong
8 papers · 2 as a resident
Adam Kibel
4 papers
Brent Rose
4 papers
Michael Hahn
4 papers
Rebecca Rakow-Penner
4 papers
LD
Leonardino Digma
3 papers · 2 as a resident
Meghana Pagadala
3 papers · 2 as a resident
Michael Gaziano
3 papers
RH
Richard Hauger
3 papers
Amar Kishan
2 papers
Brad Stish
2 papers

Grants

Role of IFN Inducible Transmembrane Protein 1 in AI-Resistant Breast Cancer
National Cancer Institute · F30
Contact PI · $116.7K · University of Kansas Medical Center
2016–2020

Clinical trials

Neu Direction: Testing the Efficacy of Adding HER Inhibition to Standard of Care in Metastatic MLH1-low Endocrine-resistant ER+/HER2- Breast Cancer
Principal investigator · Not yet recruiting · Phase 2
University of California, San Diego
2027–2035
The PREDICT Registry:
Sub-investigator · Recruiting
PreludeDx
2018–2036